Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elaine Kingwell

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Expert Review of Neurotherapeutics|September 23, 2009
Interferons and multiple sclerosis: is it plausible that beta-IFN treatment could influence the risk of cancer among MS patients?Elaine Kingwell, Helen Tremlett
Journal of Neurology, Neurosurgery, and Psychiatry|March 5, 2016
Time to wake up and smell the coffee? Coffee consumption and multiple sclerosisJosé Maria Andreas Wijnands, Elaine Kingwell
Neurology|December 10, 2009
The natural history of primary progressive multiple sclerosisMarcus Koch, Elaine Kingwell, Peter Rieckmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 20, 2010
The natural history of secondary progressive multiple sclerosisMarcus Koch, Elaine Kingwell, Peter Rieckmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 28, 2021
Care consumption of people with multiple sclerosis: A multichannel sequence analysis in a population-based setting in British Columbia, CanadaJonathan Roux, Elaine Kingwell, Feng Zhu, et al.
Clinical Therapeutics|February 3, 2012
Long-term persistence with the immunomodulatory drugs for multiple sclerosis: a retrospective database studyCharity Evans, Jennifer Tam, Elaine Kingwell, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 29, 2011
Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009)Afsaneh Shirani, Yinshan Zhao, Elaine Kingwell, et al.
European Journal of Neurology|June 12, 2023
Association of multiple-sclerosis-related mortality with COVID-19 and other common infections: a multiple causes of death analysisUgo Fedeli, Claudio Barbiellini Amidei, Francesco Avossa, et al.
American Journal of Epidemiology|October 30, 2020
Dealing With Treatment-Confounder Feedback and Sparse Follow-up in Longitudinal Studies: Application of a Marginal Structural Model in a Multiple Sclerosis CohortMohammad Ehsanul Karim, Helen Tremlett, Feng Zhu, et al.
Neurology|January 15, 2020
Multiple cause of death analysis in multiple sclerosis: A population-based studyKatharine Harding, Feng Zhu, Mohammed Alotaibi, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Expert Review of Neurotherapeutics|September 23, 2009
Interferons and multiple sclerosis: is it plausible that beta-IFN treatment could influence the risk of cancer among MS patients?Elaine Kingwell, Helen Tremlett
Journal of Neurology, Neurosurgery, and Psychiatry|March 5, 2016
Time to wake up and smell the coffee? Coffee consumption and multiple sclerosisJosé Maria Andreas Wijnands, Elaine Kingwell
Neurology|December 10, 2009
The natural history of primary progressive multiple sclerosisMarcus Koch, Elaine Kingwell, Peter Rieckmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 20, 2010
The natural history of secondary progressive multiple sclerosisMarcus Koch, Elaine Kingwell, Peter Rieckmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 28, 2021
Care consumption of people with multiple sclerosis: A multichannel sequence analysis in a population-based setting in British Columbia, CanadaJonathan Roux, Elaine Kingwell, Feng Zhu, et al.
Clinical Therapeutics|February 3, 2012
Long-term persistence with the immunomodulatory drugs for multiple sclerosis: a retrospective database studyCharity Evans, Jennifer Tam, Elaine Kingwell, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 29, 2011
Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009)Afsaneh Shirani, Yinshan Zhao, Elaine Kingwell, et al.
European Journal of Neurology|June 12, 2023
Association of multiple-sclerosis-related mortality with COVID-19 and other common infections: a multiple causes of death analysisUgo Fedeli, Claudio Barbiellini Amidei, Francesco Avossa, et al.
American Journal of Epidemiology|October 30, 2020
Dealing With Treatment-Confounder Feedback and Sparse Follow-up in Longitudinal Studies: Application of a Marginal Structural Model in a Multiple Sclerosis CohortMohammad Ehsanul Karim, Helen Tremlett, Feng Zhu, et al.
Neurology|January 15, 2020
Multiple cause of death analysis in multiple sclerosis: A population-based studyKatharine Harding, Feng Zhu, Mohammed Alotaibi, et al.
Pageof 8